Fidelity Investments’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,814
| Closed | -$1.6K | – | 5798 |
|
|
2024
Q2 | $1.6K | Buy |
4,814
+4,804
| +48,040% | +$1.3K | ﹤0.01% | 4754 |
|
|
2024
Q1 | $2 | Sell |
10
-47
| -82% | -$14 | ﹤0.01% | 5330 |
|
|
2023
Q4 | $18 | Sell |
57
-501
| -90% | -$129 | ﹤0.01% | 5237 |
|
|
2023
Q3 | $151 | Sell |
558
-17,092
| -97% | -$6.21K | ﹤0.01% | 4810 |
|
|
2023
Q2 | $8.91K | Sell |
17,650
-30,934
| -64% | -$18.5K | ﹤0.01% | 4189 |
|
|
2023
Q1 | $32K | Buy |
48,584
+39,656
| +444% | +$26.9K | ﹤0.01% | 3635 |
|
|
2022
Q4 | $3.1K | Buy |
8,928
+5,638
| +171% | +$2.29K | ﹤0.01% | 4399 |
|
|
2022
Q3 | $1K | Sell |
3,290
-44,402
| -93% | -$23.2K | ﹤0.01% | 4767 |
|
|
2022
Q2 | $19K | Buy |
47,692
+44,966
| +1,650% | +$20.1K | ﹤0.01% | 3908 |
|
|
2022
Q1 | $2K | Buy |
+2,726
| New | +$2.1K | ﹤0.01% | 4729 |
|
|
2021
Q3 | – | Sell |
-3
| Closed | – | – | 5165 |
|
|
2021
Q2 | $0 | Sell |
3
-347
| -99% | -$867 | ﹤0.01% | 5012 |
|
|
2021
Q1 | $1K | Buy |
+350
| New | +$1.27K | ﹤0.01% | 3903 |
|
|
2020
Q1 | – | Sell |
-1,154
| Closed | -$2K | – | 4349 |
|
|
2019
Q4 | $2K | Buy |
+1,154
| New | +$4.01K | ﹤0.01% | 3595 |
|
Other funds holding ASXC
Fidelity Investments's ASXC Position: Q3 2024 in Review
Fidelity Investments sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 4,814 shares — an estimated $1.6K sold.
Fidelity Investments first reported a position in ASXC in Q4 2019 and held it in 13 quarters. The position peaked at $32K in Q1 2023. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.
- Fidelity Investments reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
- Fidelity Investments sold 4,814 Asensus Surgical, Inc. shares in Q3 2024, an estimated $1.6K.
- Fidelity Investments first reported a position in Asensus Surgical, Inc. in Q4 2019 and held it in 13 quarters.
- Fidelity Investments's Asensus Surgical, Inc. position peaked at $32K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.
Based on Fidelity Investments's 13F filing for Q3 2024, filed 13 Nov 2024.